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Identification of patients at risk of sudden death is essential 
if optimal preventive treatment strategies are to be devel- 
oped. In the Coronary Artery Surgery Study (CASS) Regis- 
try, 19,946 patients were analyzed to characterize baseline 
clinical, hemodynamic and angiographic features of patients 
dying from sudden cardiac death and to compare them with 
features of patients dying from other cardiac causes, of those 
dying from noncardiac causes and of survivors. Of the 
11,843 medically treated patients, 1,621 died during a mean 
follow-up period of 5.0 years: death was sudden in 557 
(34%), nonsudden but cardiac in 813 (50%) and noncardiac 
in 251(16%). In 8,103 surgically treated patients, 824 deaths 
occurred during a mean follow-up period of 5.1 years: death 
was sudden in 204 (25%), nonsudden but cardiac in 390 
(47%) and noncardiac in 230 (28%). 
Sudden cardiac death accounts for approximately 400,000 
deaths per year (14). Clinical and pathologic studies (5-18) 
have documented that ventricular dysfunction and coronary 
artery disease are the usual pathologic substrates and that 
ventricular arrhythmia is by far the most common anteced- 
ent event. Preventive treatment strategies include anti- 
arrhythmic drugs, implantable cardioverter-defibrillators or 
cardiac operation to relieve underlying ischemia or to resect 
areas of arrhythmogenesis. For these strategies to be widely 
applicable, high risk patient subsets must be identified. 
Although several studies (4-l 1) have identified patient sub- 
sets at high risk of subsequent death, there is little informa- 
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Methods 
Selection of patients. This report analyzed the Registry 
experience with 19,946 patients without prior coronary ar- 
tery bypass grafting who underwent coronary angiography 
from 1975 to 1979 for evaluation of suspected coronary 
artery disease and who were then enrolled and prospectively 
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In general, the patients (both medically and surgically 
treated) who died of cardiac causes, either suddenly or 
nonsuddenly, were similar to each other but significantly 
different from patients who either survived or died of 
noncardiac causes. Although patients with an increased 
risk of any type of cardiac death could be identified, there 
were no measures of angiographic or hemodynamic char- 
acteristics that were significantly different between patients 
with sudden cardiac death and those with nonsudden 
cardiac death. Identification of patients at high risk for 
sudden cardiac death will require approaches in addition to 
clinical, angiographic and hemodynamic assessment, such 
as electrophysiologic assessment or monitoring techniques 
to identify triggering mechanisms. 
(J Am Co11 Cardiol1989;I3:524-30) 
tion that would help distinguish patients at high risk for 
sudden cardiac death from patients at high risk for death 
from other cardiac causes (19-22). 
The purposes of this report from the Coronary Artery 
Surgery Study (CASS) Registry are 1) to characterize the 
baseline clinical, hemodynamic and angiographic features of 
patients dying from sudden cardiac death and compare them 
with the features of patients dying from other cardiac causes; 
and 2) to compare the baseline clinical, hemodynamic and 
angiographic features of patients dying from all cardiac 
causes with those of patients dying from noncardiac causes 
and of survivors. 
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followed up. Follow-up data regarding vital status were 
complete for 98% of the initially enrolled patients up to 
December 1982. This analysis was not confined to random- 
ized patients but dealt with the Registry; therefore, biases 
associated with unknown variables could not be evaluated. 
Information on deaths was obtained from telephone in- 
terviews with families and from review of medical and 
autopsy records whenever possible. Deaths were classified 
as sudden cardiac death, nonsudden cardiac death and 
noncardiac death. 
Dejkitions 
Sudden cardiac death. Sudden cardiac death was defined 
as the sudden occurrence of death within 1 h after the onset 
of symptoms and generally before the availability of medical 
attention. 
Nonsudden cardiac death. This category included, among 
other causes, death from cardiogenic shock, myocardial 
infarction and chronic congestive heart failure. 
Noncardiac death. Noncardiac death was death not re- 
lated to cardiac disease and included death from trauma, 
malignancy, renal failure and chronic pulmonary disease. 
Coronary artery disease. Significant coronary artery dis- 
ease was defined as ~70% luminal diameter narrowing of the 
right, left anterior descending, or circumflex coronary artery 
or their major branches or as ~50% stenosis of the left main 
coronary artery. In patients with a dominant right or bal- 
anced coronary artery tree, significant stenosis of the left 
main coronary artery was coded as two-vessel disease in the 
absence of disease in the right coronary artery. For patients 
with a dominant left coronary artery, significant stenosis of 
the left main coronary artery was coded as three-vessel 
disease. 
Left ventricular function. Left ventricular function was 
quantitated with the use of monoplane left ventricular angi- 
ography. The ejection fraction was calculated with the 
area-length method (23). The left ventricle was divided in the 
right anterior oblique projection into five segments; wall 
motion was coded in each segment as normal, hypokinetic, 
akinetic or dyskinetic. The following left ventricular score 
was used: 5 = normal left ventricle; 6 to 9 = only mild left 
ventricular hypokinesia; 10 to 12 = moderate left ventricular 
regional wall motion abnormalities; and > 12 = severe left 
ventricular dysfunction (4,24). 
Myocardial jeopardy index (24). This index was used to 
evaluate the importance of a specific stenosis supplying an 
area of myocardium. Anterior myocardial jeopardy was 
present when a significant left anterior descending or left 
main coronary artery stenosis occurred in conjunction with 
“viable myocardium;” viable myocardium was defined as 
normal contraction or hypokinesia but without akinesia or 
dyskinesia. Inferior myocardial jeopardy was present when a 
significant stenosis of the proximal right coronary artery (or 
left main coronary artery or circumflex coronary artery in 
the left dominant system) occurred in conjunction with 
normal or hypokinetic (as opposed to akinetic) inferior wall 
segments. 
Congestive heart failure score. This score is a count of 
four items: a history of congestive heart failure, the presence 
of pulmonary rales at baseline, the use of digitalis and the 
use of diuretics at baseline. Functional impairment due to 
congestive heart failure was assessed with a score that 
ranged from 0 (no congestive heart failure) to 5 (symptoms of 
severe congestive heart failure). 
Statistical Methods 
Within the medically and surgically treated patient co- 
horts, baseline characteristics were compared for four 
groups of patients: 1) those with sudden cardiac death, 2) 
those with nonsudden cardiac death, 3) those with noncar- 
disc death, and 4) those who were alive at the end of 
follow-up. Univariate comparisons among the four groups 
were made by chi-square tests. Each chi-square comparison 
among the four groups was separated into three components: 
1) a comparison of patients who had sudden cardiac death 
with those who had nonsudden but also cardiac death, 2) a 
comparison of patients who had noncardiac death with 
patients who were alive, and 3) a comparison of patients 
dying of cardiac causes (sudden and nonsudden) with all 
other patients (including patients dying of noncardiac causes 
and those alive at follow-up). By this method, differences 
among the four groups were resolved into comparisons 
between pairs of groups. 
Assignment to medical or surgical therapy was made by 
the patient’s primary physician on the basis of clinical 
judgment and not according to a randomization scheme. The 
surgically treated group included patients who had coronary 
artery bypass operation within 3 years after enrollment in the 
Registry. Seventy-six patients who died on the day of 
operation were not included in the surgical group. The 
medically treated group included patients who did not have 
a bypass operation. Patients who had had any cardiac 
operation before enrollment were excluded from both 
groups. The medically and surgically treated groups were 
not defined to be comparable in this study. The medically 
treated group included patients with operable vessels (4), 
those with inoperable coronary artery disease and those with 
normal coronary arteries undergoing catheterization for sus- 
pected coronary disease. 
Results 
Medically Treated Patients 
Mortality. There were 11,843 patients who did not have a 
bypass operation. During a mean follow-up period of 5 
years, 1,621 deaths occurred (Fig. 1). Death due to cardiac 
526 HOLMES ET AL. JACC Vol. 13, No. 3 
RISK FACTORS FOR SUDDEN CARDIAC DEATH March 1, 1989524-30 
Medical treatment 
n= 1,621 
Cardiac 
causes 
but not 
sudden 
death 
Surgical treatment 
n=624 
Figure 1. Causes of death in medically and surgically treated pa- 
tients. 
causes occurred in 1,370 patients (12%). Of these deaths 
from cardiac causes, 557 (41%) were sudden. Death was due 
to a noncardiac cause in 251 patients (2%), and 10,222 
patients (86%) survived to the end of follow-up. 
Clinical characteristics (Table 1). Baseline characteristics 
for patients who had sudden cardiac death, death from other 
causes or death from noncardiac causes and for patients who 
were alive at the end of follow-up are given in Table 1. 
Patients with inoperable and operable conditions and pa- 
tients with normal or mildly diseased coronary arteries are 
included in these groups. There were significant differences 
(p 5 0.0008) among the four patient categories for all of the 
baseline characteristics. 
Sudden versus nonsudden cardiac death (Table 1). In 
general, the patients who died of cardiac causes, either 
sudden or nonsudden, were similar to each other but signif- 
icantly different from patients who either survived or died of 
noncardiac causes. When patients who had nonsudden car- 
diac death were compared only with patients who had 
sudden cardiac death, there were more similarities than 
differences. The groups were similar in all characteristics 
(p > 0.05) with only five exceptions: patients with sudden 
cardiac death were more often male (p = O.Ol), had unstable 
angina less often (p = 0.007), used digitalis less often (p = 
0.002), had ST segment depression at rest less often (p = 
0.002) and had a lower congestive heart failure score (p = 
0.04). None of the measures of angiographic or hemody- 
namic characteristics was significantly different between 
patients with sudden cardiac death and those with nonsud- 
den cardiac death. When the patients who had a cardiac 
death (sudden or nonsudden) were compared with all other 
patients (survivors and patients who had a noncardiac 
death), all the variables were significantly different (p 5 
0.004). 
Surgically Treated Patients 
cause in 230 patients; 7,279 patients (90%) survived to the 
end of follow-up. 
Sudden versus nonsudden cardiac death (Table 2). Base- 
line characteristics for surgically treated patients are shown 
in Table 2. As was found in the medically treated patients, 
there were significant differences (p I 0.03) among the 
groups for all characteristics. When compared only with 
patients who had nonsudden cardiac death, patients with 
sudden cardiac death were similar in many characteristics 
(p > 0.05) but were more often male (p = 0.004) and less 
often used nitrates (p = 0.03) or Padrenergic blockers (p = 
0.006). As was found in the medically treated patients, none 
of the measures of angiographic or hemodynamic character- 
istics was significantly different between patients with sud- 
den cardiac death and those with nonsudden cardiac death. 
When the patients who had cardiac death (sudden and 
nonsudden) were compared with all other patients (survivors 
and patients who had noncardiac death), all the variables 
were significantly different (p 5 0.02) except for a history of 
use of nitrates (p = 0.05). 
Discussion 
Given the magnitude of the problem of sudden death, 
there has been intense interest in identifying high risk 
subsets of patients. With the development of newer and 
more effective antiarrhythmic drugs and documentation of 
the efficacy of implantable cardioverter-defibrillators, there 
is justifiable enthusiasm that the ventricular arrhythmias that 
result in sudden cardiac death can be prevented or treated 
(25-31). Because these therapeutic strategies are costly and 
may be associated with morbidity or even mortality (for 
example, a proarrhythmic effect with drugs), it is advisable 
to apply them only in high risk subsets. 
Incidence of sudden and nonsudden cardiac death. In this 
large prospective study, we have confirmed previous studies 
indicating significant clinical, angiographic and hemody- 
namic differences between patients who die suddenly and 
survivors @t-7,13,15,19-22,32,33). The factors associated 
with increased sudden death rates include impaired left 
ventricular function, severe and extensive coronary artery 
disease, ST segment depression and ventricular ectopic 
activity. However, although many of these variables are 
sensitive for sudden death, their specificity is poor (19,21, 
22). Despite the frequency with which these factors occurred 
in this population, the incidence of sudden cardiac death was 
low: 4.7% in the medically treated group and 2.5% in the 
surgically treated group. The decreased incidence of sudden 
cardiac death in surgically treated patients has been previ- 
ously documented (4,17,34,35). The incidence of nonsudden 
cardiac death was also low: 6.9% in the medically treated 
group and 4.8% in the surgically treated group. We have 
presented the risk factors separately for patients who did and 
did not have a coronary artery bypass operation. The event 
rates in the two groups should not be compared with each 
Mortality. There were 8,103 patients who had operation 
within 3 years after enrollment in the Registry. During a 
mean follow-up of 5.1 years, 824 deaths occurred (Fig. 1). A 
cardiac cause of death was most common, occurring in 594 
patients (7.3%). Of these deaths from cardiac causes, 204 
(34%) were sudden death. Death was due to a noncardiac 
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Table 1. Baseline Characteristics for 11,843 Medically Treated Patients 
Variable 
Sudden Cardiac 
Death (n = 557) 
No. % 
Nonsudden 
Cardiac Death Noncardiac 
(n = 813) Death (n = 251) Alive (n = 10,222) 
No. % P No. % No. % - 
Clinical 
Male gender 
History of Ml 
History of HBP 
History of cardiac arrest 
Unstable angina 
Severity of angina 
(CHC III or IV) 
CHF score 23 
Functional impairment 
due to CHF 
(moderate to severe) 
Drug therapy 
Antiarrhythmic 
Nitrates 
Padrenergic blockers 
Digitalis 
Electrocardiographic 
ST segment depression 
at rest 
Arrhythmia 
Angiographic 
Normal vessels 
Minimal disease 
One-vessel disease 
Two-vessel disease 
Three-vessel disease 
LMCA, 250% 
narrowing 
Prox LAD, 270% 
narrowing 
Prox RCA. 270% 
narrowing 
Prox LCx, 270% 
narrowing 
Hemodynamic 
Cardiomegaly (moderate 
or severe) 
EF < 0.50t 
LV score 210 
Myocardial jeopardy 
Anterior 
Inferior 
Both 
419 86* 656 81 0.01 188 75 6,769 66 
408 73 598 74 0.87 131 52 3.970 39 
212 38 336 41 0.23 97 39 3,301 32 
45 8 83 IO 0.18 16 6 368 4 
115 21* 219 27 0.007 45 18 1,596 16 
203 36 335 41 0.19 53 21 2.189 21 
145 26* 252 31 0.04 28 11 307 3 
120 22 214 26 0.05 21 8 313 3 
116 21 161 20 0.65 30 12 860 8 
264 47 427 53 0.06 103 41 4,378 43 
195 35 321 40 0.09 87 35 4,292 42 
212 38* 378 47 0.002 59 24 1,258 12 
124 23* 244 31 0.002 44 18 757 8 
126 23 179 22 0.51 44 I8 1,184 12 
21 4 23 3 
31 6 28 3 
84 15 135 17 
164 30 211 26 
252 46 408 51 
53 10 105 13 
0.09 
0.05 
38 15 3,712 37 
54 22 1,784 18 
71 29 2,289 22 
36 15 1.415 14 
49 20 934 9 
6 2 128 1 
228 41 355 
344 
197 
171 
343 
544 
147 
110 
106 
44 0.28 41 17 1.116 
1,353 
539 
II 
224 41 43 0.45 56 23 13 
125 23 2s 0.42 21 9 5 
98 21 25 0.07 12 6 235 3 
238 61 
361 67 
63 0.49 55 28 1,312 17 
71 0.16 76 32 1,780 18 
87 16 
87 16 
77 14 
18 
14 
13 
0.51 30 12 984 10 
32 13 1,103 11 
19 8 429 4 
*p < 0.04 for differences between group with sudden cardiac death and group with nonsudden cardiac death; tpercentages are based on cases with known 
ejection fraction data. CHC = Canadian Heart Association functional class: CHF = congestive heart failure; EF = ejection fraction; HBP = high blood pressure; 
LAD = left anterior descending coronary artery; LCx = left circumflex coronary artery: LMCA = left main coronary artery; LV = left ventricular; MI = 
myocardial infarction; Prox = proximal; RCA = right coronary artery. 
other because the groups were not defined to be comparable. death for medically and surgically treated patients in the 
The medical group included patients who were surgical Registry has been published (4). 
candidates, but it also included patients who had normal Identification of patients at risk for sudden cardiac death. 
coronary arteries or minimal disease and those who were This current study goes further in detailing the problems 
judged to be inoperable. A comparison of rates of sudden associated with identifying subsets of patients at high risk for 
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Table 2. Baseline Characteristics for 8,103 Surgically Treated Patients 
Nonsudden 
Sudden Cardiac Cardiac Death 
Death (n = 204) (n = 390) 
Variable No. % No. % 
Noncardiac 
Death 
(n = 230) Alive (n = 7,279) 
P No. % No. % 
Clinical 
Male gender 
History of MI 
History of HBP 
History of cardiac arrest 
Unstable angina 
Severity of angina 
(CHC III or IV) 
CHF score ~3 
Functional impairment due to 
CHF (moderate to severe) 
Drug therapy 
Antiarrhythmic 
Nitrates 
padrenergic blockers 
Digitalis 
Electrocardiographic 
ST segment depression at rest 
Arrhythmia 
Angiographic 
One vessel disease 
Two vessel disease 
Three vessel disease 
LMCA, ~50% narrowing 
Prox LAD, ~70% narrowing 
Prox RCA, ~70% narrowing 
Prox LCx, 270% narrowing 
Hemodynamic 
Cardiomegaly (moderate or 
severe) 
EF < O.SOi 
LV score 2 10 
Myocardial jeopardy 
Anterior 
Inferior 
Both 
178 87* 302 77 0.004 189 82 6,155 85 
156 11 273 70 0.09 142 62 3,890 54 
97 48 166 43 0.25 96 42 2,518 35 
23 I1 32 8 0.21 14 6 321 5 
90 44 184 41 0.48 106 46 2,867 39 
121 59 259 67 0.21 138 60 4,207 58 
32 16 72 19 0.40 22 10 222 3 
32 16 50 13 0.34 19 8 183 3 
45 22 67 17 0.16 26 11 609 8 
119 58* 262 68 0.03 143 62 4,378 60 
94 46* 225 58 0.006 145 63 4,345 60 
69 34 151 39 0.22 61 27 921 13 
70 36 121 32 0.41 51 23 1,061 15 
40 21 75 20 0.91 34 15 832 12 
17 8 35 9 
51 25 98 25 
136 67 253 65 
42 21 75 19 
107 53 213 55 
104 51 193 50 
62 30 119 31 
0.76 
0.71 
0.57 
0.84 
0.94 
39 17 1,404 19 
53 23 2,365 33 
136 59 3,421 47 
45 20 1,013 14 
128 56 3,250 45 
96 42 2,909 40 
53 23 1,689 23 
25 14 44 14 0.92 13 7 205 3 
91 57 131 50 0.18 47 29 1,254 23 
114 59 220 60 0.79 79 36 1,935 28 
40 20 83 22 
46 23 91 24 
49 24 86 22 
0.91 31 14 1,253 17 
89 39 2,269 31 
58 25 2,261 31 
*p 5 0.03 for differences between group with sudden cardiac death and group with nonsudden cardiac death; ipercentages are based on cases with known 
ejection fraction data. Abbreviations ai in Table 1. 
sudden death. In this study, there were many significant interest. Although some studies have documented an in- 
differences between patients dying suddenly and those alive creased incidence of sudden death in patients treated with 
at 5 years; however, there were few differences between digitalis, others (36-39) have not. An analysis of 2,600 
patients dying suddenly and those having nonsudden but patients in the Registry did not identify an independent risk 
cardiac death. The differences that were statistically signif- of digitalis therapy when controlling for angiographic, hemo- 
icant seemed small in a clinical context. dynamic and clinical variables (39). 
In the medically treated group, patients with sudden In the surgically treated group, three clinical variables 
cardiac death were more often male, had somewhat less were significantly different between the groups with sudden 
unstable angina, were less frequently taking digitalis, were cardiac death and nonsudden cardiac death, including gen- 
more likely to have a low congestive heart failure score and der and the use of nitrates and beta-adrenergic blockers. The 
had a decreased frequency of ST segment depression at rest. biologic significance of these daerences is unclear because 
The association of sudden death and digitalis in patients with of the considerable overlap between patients dying suddenly 
coronary artery disease has been the subject of considerable and those with nonsudden cardiac death. 
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For both the medically and the surgically treated pa- 
tients, there were no significant differences in angiographic 
or hemodynamic characteristics that may have allowed for 
identification of patients at risk for sudden death. This is an 
analysis of observational data and the impact associated with 
unknown or unmeasured variables, for example Holter elec- 
trocardiographic monitoring, could not be evaluated. 
Clinical implications. Identification of patients at risk of 
sudden cardiac death is essential if optimal treatment strat- 
egies are to be developed. The current study documents 
that, although clinical, angiographic and hemodynamic fac- 
tors that are associated with an increased risk of cardiac 
death can be identified, they do not allow identification of 
patients with a specific type of cardiac death. The similarities 
between patients who had sudden cardiac death and those 
who had nonsudden cardiac death imply a common patho- 
logic substrate, namely, severe coronary artery disease and 
left ventricular dysfunction. Sudden cardiac death is pre- 
sumably the result of a dynamic sequence of events that 
interact with the substrate and result in a sustained fatal 
ventricular arrhythmia. The precipitating mechanisms are 
multifactorial. They could be ischemic, resulting from a fixed 
lesion or plaque rupture with thrombotic occlusion, or they 
could be primarily electrical (40-42). Studies aimed at iden- 
tifying the triggering mechanism for sudden cardiac death, 
whether ischemic, thrombotic or electrical, are a prerequi- 
site for identification of optimal therapy-anti-ischemic, 
antithrombotic or antiarrhythmic. 
Appendix 
Cooperating Clinical Sites 
University of Alabama in Birmingham. William J. Rogers, MD,* Rich- 
ard 0. Russell, Jr., MD, Albert Oberman, MD, Nicholas T. Kouchoukos, MD 
Albany Medical College. Eric D. Foster, MD,* Julio A. Sosa, MD,* Joseph 
T. Doyle, MD, Martin F. McKneally, MD, Joseph B. Mcllduff, MD, Harry 
Odabashian, MD, Thomas M. Older, MD. 
Boston University. Thomas Ryan, MD,* David Faxon, MD, Laura 
Wexler, MD. Robert L. Berger. MD, Donald Weiner, MD, Carolyn H. 
McCabe, BS. 
Loma Linda University. Joan Coggin, MD*. 
Marshfield Medical Foundation, Inc. and Marshfield Clinic. William 
Myers, MD,* Richard D. Sautter, MD,* John N. Browell. MD, Dieter M. 
Voss, MD, Robert D. Carlson, MD. 
Massachusetts General Hospital. J. Warren Harthorne, MD,* W. Gerald 
Austen, MD.* Robert Dinsmore, MD, Frederick Levine, MD, John McDer- 
mott, MD. 
Mayo Clinic and Mayo Foundation. Robert L. Frye, MD,* Bernard J. 
Gersh MD, David R. Holmes, MD, Michael B. Mock, MD, Hartzell B. Schaff. 
MD, Ronald E. Vlietstra, MD, 
Miami Heart Institute. Arthur .I. Gosselin. MD,* Parry B. Larsen, MD, 
Paul Swaye, MD. 
Montreal Heart Institute. Martial G. Bourassa, MD,* Claude Goulet, MD, 
Jacques Lesperance, MD. 
New York University. Ephraim Glassman, MD,* Michael Schloss, MD 
St. Louis University. George Kaiser, MD,* J. Gerard Mudd, MD,* Robert 
D. Wiens, MD, Hendrick B. Barner, MD, John E. Codd, MD, Denis H. 
Tyras, MD, Vallee L. Willman, MD, Bernard R. Chaitman, MD. 
St. Luke’s Hospital Center. Harvey G. Kemp, Jr., MD,* Airlie Cameron, 
MD. 
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Stanford University. Edwin Alderman, MD,* Francis H. Koch, MD, 
Paul R. Cipriano, MD, James F. Silverman, MD, Edward B. Stinson, MD. 
Medical CoUege of Wisconsin. Felix Tristani. MD.* Harold L. Brooks, 
MD,* Robert J. Flemma, MD. 
Yale University. Lawrence S. Cohen, MD,* Rene Langou, MD, Alexan- 
der S. Geha. MD, Graeme L. Hammond, MD, Richard K. Shaw, MD. 
Central Electrocardiographic Laboratory 
University of Alabama. L. Thomas Sheffield, MD,* David Roitman, MD, 
Carol Troxell. BS. 
Coordinating Center 
University of Washington. Kathryn Davis, PhD,* Kevin Cain, PhD, Lloyd 
Fisher, PhD, Mary Jo Gillespie, MS, J. Ward Kennedy, MD, Richard 
Kronmal. PhD. 
Chairman of the Steeriog Committee 
Thomas Killip. MD, Beth Israel Medical Center 
National Heart, Lung, and Blood Institute 
Thomas Robertson, MD, Eugene R. Passamani, MD. Peter Frommer. MD 
* Principal Investigator. 
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